Wiley, Cochrane Library, 2(2018), 2018
DOI: 10.1002/14651858.cd008806.pub3
Wiley, Cochrane Library, 2013
DOI: 10.1002/14651858.cd008806.pub2
Full text: Download
Every day children and adults throughout the world die from acute community-acquired bacterial meningitis, particularly in low-income countries. Survivors are at risk of deafness, epilepsy and neurological disabilities. Osmotic therapies have been proposed as an adjunct to improve mortality and morbidity from bacterial meningitis. The theory is that they will attract extra-vascular fluid by osmosis and thus reduce cerebral oedema by moving excess water from the brain into the blood. The intention is to thus reduce death and improve neurological outcomes.